The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Our study estimates the sensitivity and specificity of Medicare claims to identify clinically-diagnosed dementia, and documents how errors in dementia assessment affect dementia cost estimates. We compared Medicare claims from 1993-2005 to clinical dementia assessments carried out in 2001-2003 for the Aging Demographics and Memory Study (ADAMS) cohort (n = 758) of the Health and Retirement Study. The sensitivity and specificity of Medicare claims was 0.85 and 0.89 for dementia (0.64 and 0.95 for AD). Persons with dementia cost the Medicare program (in 2003) $7,135 more than controls (P < 0.001) when using claims to identify dementia, compared to $5,684 more when using ADAMS (P < 0.001). Using Medicare claims to identify dementia results in a 110% increase in costs for those with dementia as compared to a 68% increase when using ADAMS to identify disease, net of other variables. Persons with false positive Medicare claims notations of dementia were the most expensive group of subjects ($11,294 versus $4,065, for true negatives P < 0.001). Medicare claims overcount the true prevalence of dementia, but there are both false positive and negative assessments of disease. The use of Medicare claims to identify dementia results in an overstatement of the increase in Medicare costs that are due to dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“But outside of research settings, a substantial portion of those who would meet the diagnostic criteria for Alzheimer's and other dementias are not diagnosed with dementia by a physician.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [253]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“patients with pre-hospitalization diagnosis of dementia were identified using a validated algorithm developed by Taylor and colleagues (ICD-9 codes 331.0, 331.1, 331.2, 331.7, 290.0, 290.1, 290.10, 290.11, 290.12, 290.13, 290.20, 290.21, 290.3, 290.40, 290.41, 290.42, 290.43, 294.0, 294.1, 294.8, and 797).39”
From Discharge Communication of Dementia-Related Neuropsychiatric Symptoms and Care Management Strategies during Hospital to Skilled Nursing Facility Transitions (2021) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“For example, the positive predictive value of a dementia claim in U.S. Medicare claims is only 56% (Taylor et al. 2009).”
From Exposure to Air Pollution in Relation to Risk of Dementia and Related Outcomes: An Updated Systematic Review of the Epidemiological Literature (2021) · cites this paper as Taylor et al. 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148 · cited 2×
“We also compared the agreement of ADAMS and Medicare claims diagnoses by calculating the kappa statistic to estimate agreement between ADAMS and Medicare claims [29].”
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 1×
“The increasing number of persons diagnosed with dementia is a defining demographic fact of American society that will have a profound impact on both families and the formal health care system [1].”
The quality of health care delivered to adults in the United States
McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., & Kerr, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa022615 · Cited by 5,079
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932 · cited 5×
“However, this level of education is not unusual for this sample and education was not found to be a multivariate predictor of agreement, though education has been found to be a significant predictor of dementia in past work using ADAMS [7].”
InfluentialSelf-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787 · cited 1×
“A series of dementia prevalence estimates have been reported over time [3–6], each using different study samples and methods of disease identification.”
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Research works printed but not linked: 3
- [6]United States General Accounting Office. Alzheimer’s Disease: Estimates of Prevalence in the United States. Washington: United States General Accounting Office; 1998. [Google Scholar]
- [21]American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3. Washington, D.C: American Psychiatric Association; 1987. Revised. [Google Scholar]
- [22]American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Association; 1994. [Google Scholar]
Cited by
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
Matthews, K. A., Xu, W., Gaglioti, A. H., Holt, J. B., Croft, J. B., Mack, D., & McGuire, L. C. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3063 · Cited by 1,124
“Medicare claims data are useful for epidemiological surveillance of dementia because beneficiaries are thought to be representative of population aged 65 years and older [11,12].”
BackgroundMethodInfluential2025 Alzheimer's disease facts and figures
(2025) · Alzheimer's & Dementia · doi:10.1002/alz.70235 · Cited by 474
Power, M. C., Adar, S. D., Yanosky, J. D., & Weuve, J. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.06.004 · Cited by 422
Prevalence of dementia subtypes in United States Medicare fee‐for‐service beneficiaries, 2011–2013
Goodman, R. A., Lochner, K. A., Thambisetty, M., Wingo, T. S., Posner, S. F., & Ling, S. M. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.002 · Cited by 326
Shi, L., Wu, X., Danesh Yazdi, M., Braun, D., Abu Awad, Y., Wei, Y., Liu, P., Di, Q., Wang, Y., Schwartz, J., et al. (2020) · The Lancet Planetary Health · doi:10.1016/s2542-5196(20)30227-8 · Cited by 315
“In addition, a positive predictive value of 0·65 for Parkinson’s disease 30 and about 0·75 for Alzheimer’s disease and related dementias 31 has been reported when Medicare claims were used, indicating the under-diagnosed nature of neurological conditions using claims records.”
Jaakkimainen, R. L., Bronskill, S. E., Tierney, M. C., Herrmann, N., Green, D., Young, J., Ivers, N., Butt, D., Widdifield, J., & Tu, K. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160105 · Cited by 305
“…an algorithm of having more than one neurologist claim and the study using patients assessed for cognitive impair-344 ment assessed an algorithm of more than one AD inpatient or outpatient claim (Sn, Sp, and PPV of 86.5%, 56.3%, and 70.8%, and 85.5%, 85.9%, and 77.6% respectively) [27, 28].”
InfluentialIdentifying dementia cases with routinely collected health data: a systematic review
Wilkinson, T., Ly, A., Schnier, C., Rannikmäe, K., Bush, K., Brayne, C., Quinn, T. J., Sudlow, C. L. M., & On behalf of the UK Biobank Neurodegenerative Outcomes Group and Dementias Platform UK (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.016 · Cited by 279
“Studies investigated all-cause dementia [6–11,13–32], AD [6,9,15,16,23,25,26,31], vascular dementia [6,9,15–17,23,31], or unspecified dementia only [12].”
InfluentialThe Value of Delaying Alzheimer’s Disease Onset
Zissimopoulos, J., Crimmins, E., & St.Clair, P. (2015) · Forum for Health Economics and Policy · doi:10.1515/fhep-2014-0013 · Cited by 267
“Estimates of prevalence of AD and other dementias vary widely owing to differences in (nonrepresentative) study samples, disease definitions, and methods of diagnosis and identification (Ostbye et al. 2008; Plassman et al. 2008; Taylor et al. 2009; Brookmeyer et al. 2011; Wilson et al. 2011; Hebert et al. 2013).”
BackgroundDelgado-Saborit, J. M., Guercio, V., Gowers, A. M., Shaddick, G., Fox, N. C., & Love, S. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143734 · Cited by 246
“The MMSE has been widely used to assess general cognitive performance aswell as cognitive impairment, though it was specifically designed as a screen for early impairment and is relatively poor at assessing some aspects of cognitive performance (Tombaugh and McIntyre, 1992).”
MethodShi, L., Steenland, K., Li, H., Liu, P., Zhang, Y., Lyles, R. H., Requia, W. J., Ilango, S. D., Chang, H. H., Wingo, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27049-2 · Cited by 239
“This is supported by the findings of Taylor et al. (2009), who compared Medicare data to clinical diagnoses considered as the gold standard, and found that the sensitivity of dementia was 0.85 but was considerably lower, 0.65, for AD.”
ResultInfluentialDementia Diagnosis Disparities by Race and Ethnicity
Lin, P.-J., Daly, A. T., Olchanski, N., Cohen, J. T., Neumann, P. J., Faul, J. D., Fillit, H. M., & Freund, K. M. (2021) · Medical Care · doi:10.1097/mlr.0000000000001577 · Cited by 239
“Second, we assessed dementia severity at diagnosis, measured by: (1) cognitive function, that is, the Telephone Interview for Cognitive Status (TICS) scores for selfrespondents and the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) scores for respondents represented by a proxy; and (2) functional…”
MethodEl-Hayek, Y. H., Wiley, R. E., Khoury, C. P., Daya, R. P., Ballard, C., Evans, A. R., Karran, M., Molinuevo, J. L., Norton, M., & Atri, A. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-190426 · Cited by 216
Weuve, J., Bennett, E. E., Ranker, L., Gianattasio, K. Z., Pedde, M., Adar, S. D., Yanosky, J. D., & Power, M. C. (2021) · Environmental Health Perspectives · doi:10.1289/ehp8716 · Cited by 209
“…attention when these data are used in studies of air pollution, even in settings that provide universal health care for older adults or expansive socialized health care (McGuinness et al. 2019; Power et al. 2020; Rizzuto et al. 2018; Solomon et al. 2014; Taylor et al. 2009; Wilkinson et al. 2018).”
Recommendations for optimal ICD codes to study neurologic conditions: A systematic review
St. Germaine-Smith, C., Metcalfe, A., Pringsheim, T., Roberts, J. I., Beck, C. A., Hemmelgarn, B. R., McChesney, J., Quan, H., & Jette, N. (2012) · Neurology · doi:10.1212/wnl.0b013e3182684707 · Cited by 206
Amjad, H., Carmichael, D., Austin, A. M., Chang, C.-H., & Bynum, J. P. W. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.3553 · Cited by 195
Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States
Deb, A., Thornton, J. D., Sambamoorthi, U., & Innes, K. (2017) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1313118 · Cited by 190
“Claimbased studies use inpatient and outpatient claims to identify ADRD and do not have high sensitivity and specificity in identifying ADRD [27,28].”
BackgroundMethodResultInfluentialEffect of pioglitazone medication on the incidence of dementia
Heneka, M. T., Fink, A., & Doblhammer, G. (2015) · Annals of Neurology · doi:10.1002/ana.24439 · Cited by 185
Tsoy, E., Kiekhofer, R. E., Guterman, E. L., Tee, B. L., Windon, C. C., Dorsman, K. A., Lanata, S. C., Rabinovici, G. D., Miller, B. L., Kind, A. J. H., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0399 · Cited by 182
Interpretable Representation Learning for Healthcare via Capturing Disease Progression through Time
Bai, T., Zhang, S., Egleston, B. L., & Vucetic, S. (2018) · Proceedings of the 24th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining · doi:10.1145/3219819.3219904 · Cited by 180
“For example, EHR data have been widely used in various healthcare research tasks such as risk prediction [15, 16, 33], retrospective epidemiologic studies [17, 26, 29] and phenotyping [12, 31].”
MethodDeaths in the United States among persons with Alzheimer's disease (2010–2050)
Weuve, J., Hebert, L. E., Scherr, P. A., & Evans, D. A. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.004 · Cited by 173
“Ironically, however, the number of cases who are missing documentation in Medicare claims (sensitivity, 85%) is more than offset by the number of noncases that claims data identify as having dementia (specificity, 89%) [29].”
BackgroundDeFina, L. F., Willis, B. L., Radford, N. B., Gao, A., Leonard, D., Haskell, W. L., Weiner, M. F., & Berry, J. D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00005 · Cited by 169
“First, the dementia diagnosis was based on Medicare claims data and not on clinically detailed data sources, but these data have been reported to be largely concordant with clinical diagnoses of dementia in an Alzheimer disease registry (39) and have a sensitivity of 85% and specificity of 89% for dementia when compar…”
MethodRacial disparities and temporal trends in dementia misdiagnosis risk in the United States
Gianattasio, K. Z., Prather, C., Glymour, M. M., Ciarleglio, A., & Power, M. C. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.11.008 · Cited by 168
“Our overall findings are consistent with prior comparisons of formal dementia ascertainment versus Medicare claims data, which found Medicare claims to have 29% to 87% sensitivity and 89% to 95% specificity in identifying dementia, suggesting a greater degree of underdiagnosis than overdiagnosis [1,2].”
BackgroundResultInfluentialZhang, B., Weuve, J., Langa, K. M., D’Souza, J., Szpiro, A., Faul, J., Mendes de Leon, C., Gao, J., Kaufman, J. D., Sheppard, L., et al. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.3300 · Cited by 164
Self-citationValidation of the V66.7 Code for Palliative Care Consultation in a Single Academic Medical Center
Hua, M. S., Li, G., Clancy, C. B., Morrison, R. S., & Wunsch, H. (2016) · Journal of Palliative Medicine · doi:10.1089/jpm.2016.0363 · Cited by 168
Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes
Orkaby, A. R., Cho, K., Cormack, J., Gagnon, D. R., & Driver, J. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004586 · Cited by 161
“In addition, using claims data in the VA may lead to an underrepresentation of dementia cases while Medicare codes may lead to an overrepresentation of cases.(23,34) This is a retrospective study, although we used statistical methods to ensure robust results.”
MethodAdherence to Statin Therapy Among US Adults Between 2007 and 2014
Colantonio, L. D., Rosenson, R. S., Deng, L., Monda, K. L., Dai, Y., Farkouh, M. E., Safford, M. M., Philip, K., Mues, K. E., & Muntner, P. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010376 · Cited by 151
Validation of Claims Algorithms to Identify Alzheimer’s Disease and Related Dementias
McCarthy, E. P., Chang, C.-H., Tilton, N., Kabeto, M. U., Langa, K. M., & Bynum, J. P. W. (2022) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glab373 · Cited by 140
Self-citationStatins, cognition, and dementia-systematic review and methodological commentary
Power, M. C., Weuve, J., Sharrett, A. R., Blacker, D., & Gottesman, R. F. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.35 · Cited by 150
Shi, L., Zhu, Q., Wang, Y., Hao, H., Zhang, H., Schwartz, J., Amini, H., van Donkelaar, A., Martin, R. V., Steenland, K., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211282119 · Cited by 145
“This algorithm has been shown to be reasonably accurate in classifying diseases based on validation studies such as those by Taylor et al. (46, 47) who found high sensitivity for dementia (0.85) but lower for AD (0.65).”
MethodInfluentialThe prevalence and incidence of early‐onset dementia among adults with autism spectrum disorder
Vivanti, G., Tao, S., Lyall, K., Robins, D. L., & Shea, L. (2021) · Autism Research · doi:10.1002/aur.2590 · Cited by 148
“…2012; Geldmacher et al., 2013, 2014) and across different groups, including individuals with intellectual disability (Huang et al., 2018), with data showing that Medicare claims have a sensitivity and specificity of 0.85 and 0.89 for dementia compared with clinical assessment (Taylor et al., 2009).”
ResultInfluentialThorpe, C. T., Gellad, W. F., Good, C. B., Zhang, S., Zhao, X., Mor, M., & Fine, M. J. (2015) · Diabetes Care · doi:10.2337/dc14-0599 · Cited by 140
Mortamais, M., Gutierrez, L.-A., de Hoogh, K., Chen, J., Vienneau, D., Carrière, I., Letellier, N., Helmer, C., Gabelle, A., Mura, T., et al. (2021) · Environment International · doi:10.1016/j.envint.2020.106376 · Cited by 128
Dementia, Alzheimer’s Disease, and Mortality after Hemodialysis Initiation
McAdams‐DeMarco, M., Daubresse, M., Bae, S., Gross, A. L., Carlson, M. C., & Segev, D. L. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10150917 · Cited by 138
“95, respectively, for Alzheimer’s disease (22).”
Tsai, T.-L., Lin, Y.-T., Hwang, B.-F., Nakayama, S. F., Tsai, C.-H., Sun, X.-L., Ma, C., & Jung, C.-R. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108638 · Cited by 130
Layton, J. B., Li, W., Yuan, J., Gilman, J. P., Horton, D. B., & Setoguchi, S. (2020) · PLOS ONE · doi:10.1371/journal.pone.0243665 · Cited by 112
“We identified disease-based cohorts of patients aged�65 years among US Medicare beneficiaries with fee-for-service parts A, B, and D coverage who were discharged alive from the hospital with International Classification of Diseases 9 Revision Clinical Modification (ICD-9-CM) codes for heart failure [22], myocardial in…”
MethodChen, Y., Tysinger, B., Crimmins, E., & Zissimopoulos, J. M. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.04.003 · Cited by 129
“[10] compared dementia diagnoses in Medicare claims to clinical examinations in the 2001–2003 Aging Demographic and Memory Study (ADAMS), a small subsample of the HRS with few minority respondents, and reported sensitivity of 85% and a specificity of 89%.”
ResultFinancial Presentation of Alzheimer Disease and Related Dementias
Nicholas, L. H., Langa, K. M., Bynum, J., & Hsu, J. W. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.6432 · Cited by 138
Self-citationLin, P., Zhong, Y., Fillit, H. M., Chen, E., & Neumann, P. J. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14227 · Cited by 127
Rahman, M., White, E. M., Mills, C., Thomas, K. S., & Jutkowitz, E. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12285 · Cited by 119
Risk factors for dementia after critical illness in elderly medicare beneficiaries
Guerra, C., Linde-Zwirble, W. T., & Wunsch, H. (2012) · Critical Care · doi:10.1186/cc11901 · Cited by 110
“x) [14,16] or with any diagnosis for mild cognitive impairment (331.”
BackgroundMethodInfluentialEvaluation of Medicare Claims Data as a Tool to Identify Dementia
Lee, E., Gatz, M., Tseng, C., Schneider, L. S., Pawluczyk, S., Wu, A. H., & Deapen, D. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-181005 · Cited by 102
“[3, 20]; the other study did not include normal individuals [19].”
InfluentialLeibson, C. L., Long, K. H., Ransom, J. E., Roberts, R. O., Hass, S. L., Duhig, A. M., Smith, C. Y., Emerson, J. A., Pankratz, V. S., & Petersen, R. C. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.01.007 · Cited by 110
Neuman, H. B., Weiss, J. M., LEVERSON, G. E., O’Connor, E. S., Greenblatt, D. Y., LoConte, N. K., Greenberg, C. C., & Smith, M. A. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2721-8 · Cited by 114
“11, 294,8, and 797).(26) Disability was indirectly assessed by examining home oxygen use and mobility.”
Identifying Medicare beneficiaries with dementia
Moura, L. M. V. R., Festa, N., Price, M., Volya, M., Benson, N. M., Zafar, S. F., Weiss, M., Blacker, D., Normand, S. T., Newhouse, J. P., et al. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17183 · Cited by 106
“The applicability of these findings, however, is constrained by the inclusion of diagnostic codes that do not maintain fidelity to clinical diagnostic criteria for dementia when mapped onto ICD-10 equivalents.(5) For example, several of the ICD-9 diagnostic codes used in previously validated claims-based dementia defi…”
BackgroundMethodResultInfluentialShort‐term trends in dementia prevalence in Germany between the years 2007 and 2009
Doblhammer, G., Fink, A., & Fritze, T. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.006 · Cited by 93
“A study comparing dementia diagnoses based on Medicare claims data with diagnoses based on the Aging Demographics and Memory Study (ADAMS) [24] found that Medicare claims overestimated the true prevalence of dementia and that there were both false-positive and false-negative assessments of the disease.”
BackgroundMethodInfluentialRahman, M., White, E. M., Thomas, K. S., & Jutkowitz, E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22111 · Cited by 101
(2011) · Longitudinal and Life Course Studies · doi:10.14301/llcs.v2i2.116 · Cited by 86
“This claims-based diagnostic measure does have reasonable sensitivity and specificity for dementia (0.85 and 0.89 for dementia, and 0.64 and 0.95 for Alzheimer’s disease, respectively; see Taylor et al 2009).”
MethodInfluentialSelf-citationShimbo, D., Bowling, C. B., Levitan, E. B., Deng, L., Sim, J. J., Huang, L., Reynolds, K., & Muntner, P. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002524 · Cited by 98
Risk of Dementia in Peritoneal Dialysis Patients Compared with Hemodialysis Patients
Wolfgram, D. F., Szabó, A., Murray, A. M., & Whittle, J. (2015) · Peritoneal Dialysis International · doi:10.3747/pdi.2014.00213 · Cited by 92
“Although Medicare dementia claims have 85% sensitivity and 89% specificity for identification of dementia (24), their use has not been validated in dialysis populations, with its high prevalence of cognitive impairment.”
BackgroundPsychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA
Maust, D. T., Langa, K. M., Blow, F. C., & Kales, H. C. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4452 · Cited by 83
“In addition, the sensitivity and specificity of a dementia diagnosis in observational data are limited and may lead to misclassification and bias, as mild dementia cases may be excluded or delirium cases may be inappropriately classified as having dementia (Taylor et al., 2009).”
BackgroundSelf-citationDhana, K., Beck, T., Desai, P., Wilson, R. S., Evans, D. A., & Rajan, K. B. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13081 · Cited by 90
Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014
Rosenson, R. S., Farkouh, M. E., Mefford, M. T., Bittner, V., Brown, T. M., Taylor, B., Monda, K. L., Zhao, H., Dai, Y., & Muntner, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.585 · Cited by 90
Jacobson, M., Thunell, J. A., & Zissimopoulos, J. (2020) · Health Affairs · doi:10.1377/hlthaff.2019.01795 · Cited by 83
Long-term effects of PM2.5 components on incident dementia in the northeastern United States
Li, J., Wang, Y., Steenland, K., Liu, P., van Donkelaar, A., Martin, R. V., Chang, H. H., Caudle, W. M., Schwartz, J., Koutrakis, P., et al. (2022) · The Innovation · doi:10.1016/j.xinn.2022.100208 · Cited by 74
“The abovementioned Medicare algorithm for defining dementia is primarily based on previous studies.(54,55) These two Medicare databases enabled us to create a cohort of all Medicare fee-for-service (FFS) beneficiaries in nine northeastern states (Maine, NewYork, NewJersey,”
MethodNeuman, H. B., O’Connor, E. S., Weiss, J. M., LoConte, N. K., Greenblatt, D. Y., Greenberg, C. C., & Smith, M. A. (2012) · Cancer · doi:10.1002/cncr.27765 · Cited by 91
“8, and 797.(15) Home oxygen use was Original Article”
BackgroundSchwarzkopf, L., Menn, P., Leidl, R., Wunder, S., Mehlig, H., Marx, P., Graessel, E., & Holle, R. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-165 · Cited by 74
“The accuracy of diagnoses remains uncertain, and the agreement of different data sources is insufficient regarding dementia disorders [34-37].”
BackgroundGilstrap, L., Zhou, W., Alsan, M., Nanda, A., & Skinner, J. S. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0010 · Cited by 77
Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study
Koller, D., Hua, T., & Bynum, J. P. W. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14226 · Cited by 74
Misidentification of Dementia in Medicare Claims and Related Costs
Zhu, C. W., Ornstein, K. A., Cosentino, S., Gu, Y., Andrews, H., & Stern, Y. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15638 · Cited by 74
“It is likely that the combined effects of both types of incorrect identification result in biased estimation of dementia-associated costs.(15,16,20) We aimed to examine the relationship between misidentification of dementia and costs in a largely minority, ethnically diverse cohort for whom comprehensive cognitive and…”
BackgroundMethodResultInfluentialMcWilliams, L., Farrell, C., Grande, G., Keady, J. D., Swarbrick, C., & Yorke, J. (2017) · Aging & Mental Health · doi:10.1080/13607863.2017.1348476 · Cited by 77
Sex, Race, and Age Differences in Prevalence of Dementia in Medicare Claims and Survey Data
Zhu, Y., Chen, Y., Crimmins, E. M., & Zissimopoulos, J. M. (2021) · The Journals of Gerontology: Series B · doi:10.1093/geronb/gbaa083 · Cited by 72
“Studies, however, have found that these records have measurement errors (Amjad et al., 2018; Bradford et al., 2009; Chodosh et al., 2004; Taylor et al., 2009).”
Background2026 Alzheimer's disease facts and figures
(2026) · Alzheimer s & Dementia · doi:10.1002/alz.71345 · Cited by 118
Dementia severity and the longitudinal costs of informal care in the Cache County population
Rattinger, G. B., Schwartz, S., Mullins, C. D., Corcoran, C., Zuckerman, I. H., Sanders, C., Norton, M. C., Fauth, E. B., Leoutsakos, J. S., Lyketsos, C. G., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.004 · Cited by 71
“Although a benefit of such studies is the large sample size, the sources have significant limitations such as lower sensitivity of disease ascertainment, which can lead to inaccurate estimates of individual costs [2,7].”
BackgroundLim, U., Wang, S., Park, S., Bogumil, D., Wu, A. H., Cheng, I., Haiman, C. A., Le Marchand, L., Wilkens, L. R., White, L., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12528 · Cited by 63
Dementia in the USA: state variation in prevalence
Koller, D., & Bynum, J. P. W. (2014) · Journal of Public Health · doi:10.1093/pubmed/fdu080 · Cited by 68
Shin, A., Koo, B. K., Lee, J. Y., & Kang, E. H. (2024) · BMJ · doi:10.1136/bmj-2024-079475 · Cited by 69
“21 To improve specificity of outcome ascertainment, we examined dementia defined by the diagnosis codes along with dispensing of dementia drugs (donepezil, rivastigmine, galantamine, or memantine) as a secondary outcome.”
Doblhammer, G., Fink, A., Zylla, S., & Willekens, F. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0146-x · Cited by 62
Antidepressant use in the elderly is associated with an increased risk of dementia
Wang, C., Gao, S., Hendrie, H. C., Kesterson, J., Campbell, N. L., Shekhar, A., & Callahan, C. M. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000103 · Cited by 68
The costs of dementia subtypes to California Medicare fee‐for‐service, 2015
Chen, Y., Wilson, L., Kornak, J., Dudley, R. A., Merrilees, J. J., Bonasera, S. J., Byrne, C., Lee, K. P., Chiong, W., Miller, B. L., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.03.015 · Cited by 68
“found an 86% agreement between dementia diagnoses derived from Medicare claims and based on a comprehensive and standard assessment in the Aging, Demographic and Memory Study sample (N 5 758) [37].”
MethodDementia and Alzheimer's Disease among Older Kidney Transplant Recipients
McAdams‐DeMarco, M., Bae, S., Chu, N. M., Gross, A. L., Brown, C. H., Oh, E. S., Rosenberg, P. B., Neufeld, K. J., Varadhan, R., Albert, M., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016080816 · Cited by 69
Medicare Utilization and Expenditures Around Incident Dementia in a Multiethnic Cohort
Zhu, C. W., Cosentino, S., Ornstein, K., Gu, Y., Scarmeas, N., Andrews, H., & Stern, Y. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv124 · Cited by 67
Lu‐Yao, G. L., Nikita, N., Keith, S. W., Nightingale, G., Gandhi, K., Hegarty, S., Rebbeck, T. R., Chapman, A. E., Kantoff, P. W., Cullen, J., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.07.031 · Cited by 67
Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults
Deardorff, W. J., Liu, P. L., Sloane, R. J., Houtven, C. H. V., Pieper, C. F., Hastings, S. N., Cohen, H. J., & Whitson, H. E. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15891 · Cited by 68
“Case definitions of dementia in database analyses may result in biased estimates.(48,49) Second, data on the severity of sensory impairments, dementia, and comorbidities were not available in this data set.”
BackgroundWaller, M., Mishra, G. D., & Dobson, A. J. (2017) · Emerging Themes in Epidemiology · doi:10.1186/s12982-017-0057-3 · Cited by 63
“There is evidence from other countries that some types of routinely collected data, such as United States Medicare claims (which do not have universal coverage, and cover a different range of services from the Australian Medicare), may overestimate the prevalence of dementia [38], so the use of some of the multiple li…”
ResultMedicare expenditures attributable to dementia
White, L., Fishman, P., Basu, A., Crane, P. K., Larson, E. B., & Coe, N. B. (2019) · Health Services Research · doi:10.1111/1475-6773.13134 · Cited by 61
Schwarzkopf, L., Menn, P., Leidl, R., Graessel, E., & Holle, R. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-2 · Cited by 58
“Second, the documented diagnoses cannot be verified via medical examinations; thus, their accuracy is not absolutely guaranteed [28-31].”
BackgroundA Longitudinal Analysis of the Lifetime Cost of Dementia
Yang, Z., Zhang, K., Lin, P., Clevenger, C., & Atherly, A. (2012) · Health Services Research · doi:10.1111/j.1475-6773.2011.01365.x · Cited by 58
“Second, these measurements of dementia and related conditions are based exclusively on diagnosis codes fromMedicare claims, the use of which could lead to underestimates of the prevalence of dementia (Taylor and Sloan 2000; Taylor et al. 2009).”
BackgroundNori, V. S., Hane, C. A., Martin, D. C., Kravetz, A. D., & Sanghavi, D. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0203246 · Cited by 62
Air pollution and dementia in older adults in the Ginkgo Evaluation of Memory Study
Semmens, E. O., Leary, C. S., Fitzpatrick, A. L., Ilango, S. D., Park, C., Adam, C. E., DeKosky, S. T., López, O. L., Hajat, A., & Kaufman, J. D. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12654 · Cited by 59
“14,17 These records also have limited information on key confounding factors, such as education and smoking, or potential effect modifiers, such as the apolipoprotein E (APOE) ε 4 allele, the strongest genetic predictor of Alzheimer’s disease (AD), which may increase susceptibility to the impacts…”
BackgroundFine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State
Nunez, Y., Boehme, A. K., Weisskopf, M. G., Re, D. B., Navas-Acien, A., van Donkelaar, A., Martin, R. V., & Kioumourtzoglou, M.-A. (2021) · Environmental Health Perspectives · doi:10.1289/ehp7425 · Cited by 53
Evans, D. A., Grodstein, F., Loewenstein, D., Kaye, J., & Weintraub, S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.11.008 · Cited by 55
“Another study found 85% of ADAMS cases diagnosed as demented had a Medicare claim with a dementia-related diagnosis [11].”
BackgroundKim, Y.-G., Park, D. G., Moon, S. Y., Jeon, J. Y., Kim, H. J., Kim, D. J., Lee, K.-W., & Han, S. J. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0260 · Cited by 50
“However, a previous study showed that the dementia diagnoses in claims data were quite correct when compared with clinically diagnosed dementia [26].”
ResultReceipt of Monitoring of Diabetes Mellitus in Older Adults with Comorbid Dementia
Thorpe, C. T., Thorpe, J. M., Kind, A. J. H., Bartels, C. M., Everett, C. M., & Smith, M. A. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03907.x · Cited by 59
“Although the validity of this definition has not been directly evaluated, it has only minor operational differences from a Medicare claims-based algorithm developed previously.(16,17) Using a national, nonclinical sample of older adults representing the full range of cognitive ability, the algorithm has demJAGS APRIL…”
MethodResultKasiske, B. L., Kukla, A., Thomas, D., Ives, J. W., Snyder, J. J., Qiu, Y., Peng, Y., Dharnidharka, V. R., & Israni, A. K. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.07.015 · Cited by 54
Xie, F., Colantonio, L. D., Curtis, J. R., Safford, M. M., Levitan, E. B., Howard, G., & Muntner, P. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww077 · Cited by 53
Fowler, N. R., Campbell, N. L., Pohl, G. M., Munsie, L. M., Kirson, N. Y., Desai, U., Trieschman, E. J., Meiselbach, M. K., Andrews, J. S., & Boustani, M. A. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15330 · Cited by 51
Varma, V. R., Desai, R. J., Navakkode, S., Wong, L., Anerillas, C., Loeffler, T., Schilcher, I., Mahesri, M., Chin, K., Horton, D. B., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01912-0 · Cited by 53
“When validated against a structured in-home dementia assessment, Medicare claims-based dementia identification is reported to have a positive predictive value (PPV) in the range of 65% to 78% [12].”
MethodHara, K., Tomio, J., Svensson, T., Ohkuma, R., Svensson, A. K., & Yamazaki, T. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.03.004 · Cited by 54
Dementia and Hospital Readmission Rates: A Systematic Review
Pickens, S., Naik, A. D., Catic, A., & Kunik, M. E. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000481502 · Cited by 47
Kim, Y.-G., Jeon, J. Y., Kim, H. J., Kim, D. J., Lee, K.-W., Moon, S. Y., & Han, S. J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm8010028 · Cited by 45
Dattalo, M., DuGoff, E. H., Ronk, K., Kennelty, K. A., Gilmore‐Bykovskyi, A. L., & Kind, A. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14539 · Cited by 47
Effect of Medications on Physical Function and Cognition in Nursing Home Residents with Dementia
Dutcher, S. K., Rattinger, G. B., Langenberg, P., Chhabra, P. T., Liu, X., Rosenberg, P. B., Leoutsakos, J., Simoni‐Wastila, L., Walker, L. D., Franey, C. S., et al. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12838 · Cited by 44
“89.(49) Although information on actual medication ingestion was not available using Medicare claims or the MDS, staff administer NH residents’ medications, so medication use is likely to be reliable.”
MethodThorpe, C. T., Fowler, N. R., Harrigan, K., Zhao, X., Kang, Y., Hanlon, J. T., Gellad, W. F., Schleiden, L. J., & Thorpe, J. M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14403 · Cited by 46
Metadata
- Authors
- Taylor, Jr., Østbye, T., Langa, K. M., Weir, D., & Plassman, B. L.
- Affiliations
- Center for Health Policy, Sanford Duke School of Public Policy, Duke University, Durham, NC, USA
- Duke Medical Center (US)
- University of Michigan (US)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-07-23
- Volume
- 17
- Issue
- 4
- Pages
- 807-815
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC3697480
- OpenAlex
- W1934443959
- Cited by
- 354
- References
- 29
- Citations by year
- 2026: 24 · 2025: 42 · 2024: 30 · 2023: 26 · 2022: 44 · 2021: 38 · 2020: 27 · 2019: 22 · 2018: 23 · 2017: 19 · 2016: 22 · 2015: 14 · 2014: 7 · 2013: 3 · 2012: 7
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (U01 AG 09740, U01AG009740, R01AG027010)
- National Institute of Nursing Research (R01NR008763)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- Medicare claims data, dementia
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Dementia, Female, Medicare, Humans, Insurance Claim Reporting, Male, Sensitivity and Specificity, United States, Cohort Studies, Prevalence, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.